Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0001062993-25-008341

10% owner sold 736,767 shares at an average $1.38 ($1,017,919)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PERCEPTIVE ADVISORS LLC 10% owner 2025-04-30 Sale −437,881 $1.41 $617,412 3,403,025 I
PERCEPTIVE ADVISORS LLC 10% owner 2025-05-01 Sale −298,886 $1.34 $400,507 3,104,139 I
Open-market sales · 736,767 sh · avg $1.38 · $1,017,919
Loading xslF345X05/form4.xml…